Transposagen Biopharmaceuticals, Inc., headquartered in the United States, is a pioneering entity in the biopharmaceutical industry, specialising in gene editing and cell line development. Founded in 2006, the company has established itself as a leader in providing innovative solutions for research and therapeutic applications, particularly through its proprietary technologies such as the Transposagen Gene Editing System. With a focus on creating custom cell lines and genetically modified organisms, Transposagen's unique offerings cater to the needs of academic, pharmaceutical, and biotechnology sectors. The company has achieved significant milestones, including collaborations with major research institutions and contributions to advancements in gene therapy. Renowned for its commitment to quality and innovation, Transposagen continues to solidify its market position as a trusted partner in the evolving landscape of biopharmaceutical research and development.
We don't have data for Transposagen Biopharmaceuticals, Inc., but we can show you information about their parent organization instead.
View parent company